The Hidden Hazards of E-cigarettes

Aug.29.2022
The Hidden Hazards of E-cigarettes
Electronic cigarettes are dangerous and contain addictive substances like nicotine, leading to health risks such as lung disease and cancer.

The dangers of tobacco are too numerous to list. Despite widespread public awareness campaigns warning of the dangers of tobacco, some businesses have introduced electronic cigarettes by changing concepts and packaging. These have become hugely popular, especially among young people who view them as a trendy accessory. However, the notion of trendiness hides unimaginable harm to health.


Electronic cigarettes can aid in quitting smoking and pose less of a risk than traditional cigarettes.


The dangers of tobacco are too numerous to list. In response to the widespread publicity about the hazards of tobacco throughout society, some businesses have introduced electronic cigarettes after changing their packaging and concepts. These products have become popular in the market and are eagerly sought after by countless smokers. They have even become a fashionable trend among millions of young people, but this so-called trend conceals unimaginable dangers.


Electronic cigarettes are also a form of smoking and can cause harm to the human body when inhaled.


What exactly is an electronic cigarette? It typically consists of a device and a liquid. The device is an electronic heating tool that converts the liquid into an aerosol for inhalation. The liquid is primarily composed of organic solvents such as propylene glycol and glycerin, as well as nicotine, flavorings (food-grade aromas), and additives. Some electronic cigarettes resemble traditional cigarette products, while others are shaped like pens, USB drives, lighters, and other objects.


Electronic cigarettes, which don't involve combustion, can avoid the harmful products of incomplete combustion such as tar. However, this doesn't mean that they are safe - most of the e-liquids in the market contain addictive nicotine and may even have toxic substances that traditional cigarettes don't have. Inhaling these substances can still harm the body.


Causing "popcorn lung" disease.


Electronic cigarettes may cause a severe and fatal lung disease called bronchiolitis obliterans, which is irreversible. It is caused by the chemical diacetyl found in the flavorings of e-cigarettes, which is also a major component of buttered popcorn flavoring, hence the nickname "popcorn lung".


Because the stimulation of electronic cigarettes is not as strong as that of traditional cigarettes, people who smoke them often inhale deeper. Acetoin also penetrates deeper into the lungs. Over time, the lungs become hardened and lose elasticity, affecting breathing and resembling "pork jerky.


Increase the risk of cancer and cardiovascular diseases.


Retailers often emphasize that "electronic cigarettes do not produce toxic and harmful substances such as tar and carbon monoxide in traditional cigarettes," claiming it is "healthy and safe." However, the reality is that in 2019, the 315 Evening Gala pointed out that "like traditional cigarettes, the e-liquid used in electronic cigarettes contains nicotine, which can lead to addiction if used in the long term.


Testing has shown that aerosols generated by e-cigarettes typically contain ethylene glycol, aldehydes, volatile organic compounds, polycyclic aromatic hydrocarbons, tobacco-specific nitrosamines, metals, silica particulates, and other elements. Many of these components are known toxic substances that can even be carcinogenic, and they also pose a second-hand smoke hazard. Long-term use of e-cigarettes increases the risk of developing chronic obstructive pulmonary disease, lung cancer, oral cancer, cardiovascular disease, and other health problems.


The Consumer Protection Committee of Shanghai reminds you:


It's important to note that the harm of electronic cigarettes is not limited to just one aspect. Compared to traditional cigarettes, they pose four potential health risks that should be given our attention. Firstly, the hazards of second-hand smoke are more subtle - despite e-cigarettes being marketed as "safe and harmless", people have let their guard down and are allowed to smoke in public places and at home, leading to more people being exposed to second-hand smoke, and even third-hand smoke. Secondly, e-cigarettes are more susceptible to drug abuse – the production threshold for e-cigarettes is lower, allowing ordinary people to mix different proportions of e-juice components and add various hazardous substances to it. Coupled with the relative lack of regulation over e-cigarette production, it is easier for some illegal operators to take advantage of this compared to traditional cigarettes.


Thirdly, it is easier to lure teenagers - In the pods that are sold in the market, over 90% of them are non-tobacco flavors, such as fruit, candy, and mint flavors. These novel tastes, combined with attractive and cool packaging, have successfully captured the attention of many teenagers who have poor judgement and crave novelty.


Fourthly, they are more addictive - Most electronic cigarettes contain harmful substances such as nicotine, which affects the brain's nerves and can lead to addiction. Coupled with the variety of novel flavors offered by some electronic cigarettes, people tend to lower their guard against tobacco, leading to a "gateway effect" - even non-smokers who try electronic cigarettes may develop a nicotine dependence and eventually become cigarette smokers.


Multiple strategies help promote scientific smoking cessation.


Quitting smoking requires scientific channels and professional guidance. There are increasingly standardized smoking cessation clinics in Shanghai that offer personalized assessments, tailor-made quitting plans, and follow-up support for smokers. Citizens can also call the "12320" health hotline for professional guidance or join their local health self-management group to receive help from professionals in quitting smoking through mutual assistance and peer education.


Finally, we would like to tell you:


If you use electronic cigarettes, please remain cautious regarding their use. If you have not tried them, it's best to avoid them. If you work in the tobacco industry, follow the law and refrain from selling to minors. If you know anyone, especially young people, who use e-cigarettes, please share this article with them and help them break their habit.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Ispire Q4 Revenue Rebounds 33% but Full-Year Sales Still Fall 25% as FY2027 Focus Shifts to Malaysia Manufacturing, ODM, Nicotine Pouches and Age Verification
Ispire Q4 Revenue Rebounds 33% but Full-Year Sales Still Fall 25% as FY2027 Focus Shifts to Malaysia Manufacturing, ODM, Nicotine Pouches and Age Verification
Ispire Technology reported FY2026 revenue of about $96 million, down 24.7% year over year, as U.S. cannabis-vapor hardware and European e-cigarette sales declined by $17.4 million and $12.7 million, respectively. Fourth-quarter revenue rose 32.5% to $26.7 million, while quarterly gross margin fell to 6.3%. For FY2027, the company is prioritizing Malaysia manufacturing and vapor ODM while continuing to develop nicotine pouches, IKE Tech age-verification technology and G-Mesh licensing. Ispire has not separately disclosed the revenue or profit contribution of those newer businesses.
Regulations
Sep.17 by 2Firsts Perspectives
FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
Turning Point Brands said Executive Chairman David E. Glazek will become CEO on October 1, replacing Graham Purdy, who is stepping down for personal reasons. The company narrowed its 2026 adjusted EBITDA outlook to $70 million-$80 million from $70 million-$90 million while maintaining Modern Oral gross sales guidance of $330 million-$350 million and net sales guidance of $260 million-$270 million. In the second quarter, Modern Oral net sales rose 128% to $68.4 million and accounted for 48% of company-wide net sales. Adjusted EBITDA fell 50% year over year. TPB shares closed about 10% lower on September 21.
Market
Sep.22 by 2Firsts Perspectives
Product | Philip Morris Korea Launches Two TEREA ONYX Capsule Tobacco Sticks, Expanding Portfolio to Five Lines
Product | Philip Morris Korea Launches Two TEREA ONYX Capsule Tobacco Sticks, Expanding Portfolio to Five Lines
Philip Morris Korea launched TEREA ONYX, a new tobacco stick line for IQOS ILUMA devices, on October 15, 2026. The initial products, AMANG PEARL and CALI PEARL, feature tropical-inspired flavors, Fresh Filters and capsules designed to deliver different flavor experiences before and after activation. Both are priced at KRW 4,800 per pack and are available at convenience stores nationwide and IQOS-operated stores in South Korea. The launch expands the Korean TEREA portfolio from four product lines to five, following earlier capsule tobacco stick additions in 2026.
product
Oct.23
India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
The Bombay High Court has ruled that airport duty-free shops are not exempt from India's domestic regulatory laws merely because they operate beyond the customs barrier, leaving in place a sales halt covering ZYN and FOX nicotine pouches at Mumbai's international airport. The court, however, did not determine that the products necessarily qualify as "drugs" under India's Drugs and Cosmetics Act. The retailers have four weeks to submit product information to the appropriate authorities, including CDSCO, which must complete its review within 30 days of receiving the submissions.
Sep.24
From Product Innovation to Integrated Solutions: NEXTECH Expands Its Global Heated Tobacco Solutions
From Product Innovation to Integrated Solutions: NEXTECH Expands Its Global Heated Tobacco Solutions
NEXTECH launched its NEXE Pro circumferential-heating tobacco stick globally at InterTabac 2026, as the company expands from product innovation into broader heated tobacco solutions. Amid intensifying competition across global HTP markets, NEXTECH is strengthening its R&D, manufacturing and pre-launch support capabilities to serve different types of business customers.
Industry Insight
Sep.15
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22